The inclusion and exclusion criteria mirrored those of Phase 2, with additional criteria of a BMI < 25, managing hypertension (must currently be managing HTN with medication or have either systolic BP > 140 or diastolic BP > 90), a non-smoker, and not using injectable insulin to manage diabetes mellitus if this comorbidity is present. The gene discussed is INS; the disease is hypertensive disorder.